+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pneumocystis Jirovecii Pneumonia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Postherpetic Encephalitis

Pneumocystis Jirovecii Pneumonia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Postherpetic Encephalitis

Pediatric Infectious Disease Journal 35(7): 816-817

Anti-N-methyl-D-aspartate receptor encephalitis is a neuroimmunologic disorder that has been increasingly diagnosed during the past 5 years. It provokes a predictable syndrome treated with several immunomodulatory agents, such as corticosteroids and/or biologics. We managed a child with this disease who developed Pneumocystis jirovecii pneumonia as a direct infectious complication of the use of rituximab.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058566666

Download citation: RISBibTeXText

PMID: 27093160

DOI: 10.1097/INF.0000000000001165

Related references

Postherpetic Anti-N-methyl-D-aspartate Receptor Encephalitis after Hemispherotomy in a Patient with Intractable Startle Epilepsy. Neuropediatrics 49(1): 63-67, 2017

A case of anti-N-methyl-D-aspartate receptor encephalitis with ovarian teratoma showing excellent recovery with decreasing of anti-N-methyl-D-aspartate receptor antibody. Rinsho Shinkeigaku 51(7): 499-504, 2011

Anti-N-methyl-D-aspartate receptor encephalitis that aggravates after acinetobacter baumannii pneumonia: A case report. World Journal of Clinical Cases 5(9): 368-372, 2017

The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis. Leukemia and Lymphoma 52(1): 148-149, 2011

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with colon cancer. Clinical Neurology and Neurosurgery 177: 114-116, 2019

Early operative treatment of anti-N-methyl D-aspartate (anti-NMDA) receptor encephalitis in a patient with ovarian teratoma. Clinical and Experimental Obstetrics and Gynecology 42(6): 819-821, 2016

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in a Patient with Systemic Lupus Erythematosus. Journal of Clinical Neurology 12(4): 502-504, 2016

Primary lateral sclerosis-like picture in a patient with a remote history of anti-N-methyl-D- aspartate receptor (anti-NMDAR) antibody encephalitis. Bmj Case Reports 2018, 2018

Anti- N -Methyl-d-Aspartate Receptor Encephalitis in a Patient with Alcoholism: A Rare Case Report. Frontiers in Psychiatry 8: 141, 2017

Clinical course of recovery from cognitive dysfunction in a patient with anti-N-methyl-D-aspartate receptor encephalitis. Brain and Nerve 66(10): 1219-1224, 2015

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 8: 74-77, 2017

Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurology 70(12): 1566-1568, 2014

Important differential in a patient presenting with neuropsychiatric symptoms: Anti-N-Methyl-D-Aspartate receptor encephalitis. Medical Journal of Malaysia 72(5): 306-307, 2017

The Neurocognitive Profile of an Anti-N-Methyl-D-Aspartate Receptor Encephalitis Patient Presenting With Neuropsychiatric Symptoms. Journal of Neuropsychiatry and Clinical Neurosciences 28(3): 255-256, 2017

Anesthesia for patient with anti-N-methyl-D-aspartate receptor encephalitis: A case report with a brief review of the literature. Medicine 97(50): E13651-E13651, 2018